NCT00155675View on ClinicalTrials.gov

Pseudodrynaria Coronana (Wall) Ching

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2000

Study Completion Date

January 31, 2001

Conditions
Osteoporosis
Interventions
DRUG

GUSUIBU

Trial Locations (1)

100

National Taiwan University Medical Center, Taipei

All Listed Sponsors
collaborator

Sheng Chang Pharmaceutical

INDUSTRY

lead

National Taiwan University Hospital

OTHER

NCT00155675 - Pseudodrynaria Coronana (Wall) Ching | Biotech Hunter | Biotech Hunter